Hypertension Trial, Recruiting NCT07290842 Sponsor: Gødstrup Hospital Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07290842
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have high blood pressure that is either newly diagnosed or being managed with no more than 2 blood pressure medications, with blood pressure readings within specific ranges at the screening visit.
  • People who have a type of chronic kidney disease (stages 1 to 3) caused by high blood pressure, or who had stage 1 chronic kidney disease in the last 5 years but no longer show protein in their urine after treatment.
  • People whose urine protein-to-creatinine ratio is below 500 mg/g (a measure of kidney health confirmed by a blood or urine test).
  • People whose kidneys are filtering at a rate above 30 ml/min/1.73m² (a measure of kidney function confirmed by a blood test).
  • People with a Body Mass Index (BMI) of 35 or below.
  • People who are able to follow a specific diet plan as part of the trial.
  • Women who could become pregnant must be using an accepted form of contraception (such as the pill, an implant, a hormonal or copper coil, a vaginal ring, a patch, or contraceptive injections) or be abstaining from sex — this does not apply to women who have gone through menopause, have been surgically sterilised, or whose partner has been surgically sterilised.

Who may not be able to join:

  • People who have been diagnosed with heart failure classified as moderate to severe (NYHA class II to IV).
  • People who have been diagnosed with liver failure.
  • People who have any type of diabetes.
  • People who currently have a malignant (cancerous) disease, other than a common type of non-serious skin cancer (non-melanoma skin cancer).
  • People whose kidney disease appears to be caused by something other than high blood pressure (confirm with trial site).
  • People who have previously received a kidney transplant.
  • People who have had a stroke or a temporary stroke-like episode (transient ischaemic attack).
  • People who currently have untreated heart or cardiovascular disease that is still being investigated or managed (confirm with trial site).
  • People who have had a heart attack, except in specific circumstances where the heart attack was a certain type (non-STEMI), occurred more than one year before the trial, and where the person has received appropriate treatment and medication (confirm with trial site).
  • People who are currently being treated with organic nitrate medications.
  • People who have been diagnosed with high blood pressure caused by a condition other than kidney disease — for example, narrowing of the kidney arteries or a hormonal condition causing high blood pressure.
  • People who are pregnant or breastfeeding.
  • People whose alcohol intake exceeds the recommended guidelines set by the Danish Health Authorities.
  • People taking medications for other conditions that the trial investigators believe may affect the trial results and that cannot be safely stopped during the trial (for example, beta-blockers used to treat an irregular heartbeat).
  • People who the trial investigator considers unsuitable to participate for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 004578436580

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gødstrup Hospital
Registry
ClinicalTrials.gov
Start date
8 December 2025
Est. completion
1 January 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Changes in 24 h systolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov